Literature DB >> 22782440

Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer.

Yasuo Sakamoto1, Yoshihisa Sakaguchi, Eiji Oki, Kazuhito Minami, Yasushi Toh, Takeshi Okamura.   

Abstract

BACKGROUND: The efficacy and the indications of resection of synchronous or metachronous hepatic and pulmonary metastases from colorectal cancer (CRC) are controversial. This study retrospectively reviewed the cases of CRC patients who underwent both liver and lung resection to define the appropriate indications for surgical resection in patients with hepatic and pulmonary metastases.
METHODS: A total of 39 patients with both hepatic and pulmonary metastases from CRC underwent both liver and lung resection from January 1987 to December 2009. The relapse-free survival (RFS) and overall survival (OS) from the resection for the first metastasis were evaluated by a Kaplan-Meyer analysis. Prognostic factors were analyzed using the log-rank test and a Cox proportional hazards model.
RESULTS: The median RFS and the 5-year RFS rate of all patients were 12 months and 2.6 %, respectively. The median survival time (MST) and 5-year OS rate of all patients were 66 months and 48.3 %, respectively. The MST of the patients with a long (>1 year) disease-free interval (DFI) could not be calculated, but their 5-year OS rate was 73.7 %. In contrast, the MST and 5-year OS rate of the patients with a short (<1 year) DFI were 29 months and 37.5 %, respectively. The short DFI was the only prognostic factor in the multivariate analysis.
CONCLUSIONS: Aggressive surgical resection of both hepatic and pulmonary metastases from CRC should be undertaken in selective patients, including those with a long DFI.

Entities:  

Mesh:

Year:  2012        PMID: 22782440     DOI: 10.1007/s00268-012-1708-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer.

Authors:  K Kobayashi; M Kawamura; T Ishihara
Journal:  J Thorac Cardiovasc Surg       Date:  1999-12       Impact factor: 5.209

2.  Surgical experience with hepatic colorectal metastasis.

Authors:  A L Bradley; W C Chapman; J K Wright; J W Marsh; S Geevarghese; K T Blair; C W Pinson
Journal:  Am Surg       Date:  1999-06       Impact factor: 0.688

3.  Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection.

Authors:  S Nagakura; Y Shirai; Y Yamato; N Yokoyama; T Suda; K Hatakeyama
Journal:  J Am Coll Surg       Date:  2001-08       Impact factor: 6.113

4.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

5.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

6.  Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma.

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi; Giuseppe Tonini; Patrizio Bollero; Mario Roselli; Davide Mineo; Italo Nofroni
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

7.  Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience.

Authors:  J K Mansel; A R Zinsmeister; P C Pairolero; J R Jett
Journal:  Chest       Date:  1986-01       Impact factor: 9.410

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

Review 9.  Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.

Authors:  Masayoshi Inoue; Mitsunori Ohta; Keiji Iuchi; Akihide Matsumura; Kan Ideguchi; Tsutomu Yasumitsu; Katsuhiro Nakagawa; Kenjiro Fukuhara; Hajime Maeda; Shin-ichi Takeda; Masato Minami; Yuko Ohno; Hikaru Matsuda
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

10.  Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.

Authors:  George Miller; Peter Biernacki; Nancy E Kemeny; Mithat Gonen; Robert Downey; William R Jarnagin; Michael D'Angelica; Yuman Fong; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2007-06-27       Impact factor: 6.113

View more
  12 in total

Review 1.  Oligometastatic Disease in Pancreatic Cancer - How to Proceed?

Authors:  Bernhard W Renz; Stefan Boeck; Falk Roeder; Christoph Trumm; Volker Heinemann; Jens Werner
Journal:  Visc Med       Date:  2017-02-10

2.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 3.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

4.  Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis.

Authors:  Mitsuhiro Kamiyoshihara; Hitoshi Igai; Natsuko Kawatani; Takashi Ibe; Naoki Tomizawa; Kai Obayashi; Kimihiro Shimizu; Izumi Takeyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-08

5.  Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.

Authors:  Jocelyn Bellier; Julien De Wolf; Mohamed Hebbar; Mehdi El Amrani; Christophe Desauw; Emmanuelle Leteurtre; François-René Pruvot; Henri Porte; Stéphanie Truant
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 6.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

Review 7.  Surgery for oligometastasis of pancreatic cancer.

Authors:  Fengchun Lu; Katherine E Poruk; Matthew J Weiss
Journal:  Chin J Cancer Res       Date:  2015-08       Impact factor: 5.087

8.  Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer Patients.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Toshiteru Nagashima; Seshiru Nakazawa; Kai Obayashi; Yoko Azuma; Misaki Iijima; Takayuki Kosaka; Toshiki Yajima; Hiroomi Ogawa; Soichi Tsutsumi; Motohiro Arai; Akira Mogi; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

9.  Size of metastatic deposits affects prognosis in patients undergoing pulmonary metastectomy for colorectal cancer.

Authors:  M A Javed; A R G Sheel; A A Sheikh; R D Page; P S Rooney
Journal:  Ann R Coll Surg Engl       Date:  2014-01       Impact factor: 1.891

10.  BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES.

Authors:  Orlando Jorge Martins Torres; Márcio Carmona Marques; Fabio Nasser Santos; Igor Correia de Farias; Anelisa Kruschewsky Coutinho; Cássio Virgílio Cavalcante de Oliveira; Antonio Nocchi Kalil; Celso Abdon Lopes de Mello; Jaime Arthur Pirola Kruger; Gustavo Dos Santos Fernandes; Claudemiro Quireze; André M Murad; Milton José de Barros E Silva; Charles Edouard Zurstrassen; Helano Carioca Freitas; Marcelo Rocha Cruz; Rui Weschenfelder; Marcelo Moura Linhares; Leonaldson Dos Santos Castro; Charles Vollmer; Elijah Dixon; Héber Salvador de Castro Ribeiro; Felipe José Fernandez Coimbra
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.